SAMANTHA NAPLES: Open Payments
NPI 1750868543 · MEDIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,031 in 34 payments from 13 companies in 2025. Trend: 2023 $729 · 2024 $1,701 · 2025 $1,031
Food & beverage: $1,031
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $217 |
| BridgeBio Pharma, Inc. | 1 | $151 |
| Abbott Laboratories | 1 | $147 |
| Amgen Inc. | 5 | $110 |
| AGEPHA Pharma FZ LLC | 1 | $99 |
| Esperion Therapeutics, Inc. | 4 | $67 |
| PFIZER INC. | 3 | $59 |
| E.R. Squibb & Sons, L.L.C. | 3 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
Products named: JARDIANCE, Attruby, CARDIOMEMS, REPATHA, LODOCO, NEXLETOL, ELIQUIS, VYNDAQEL.
Industry payments across PA — which companies pay providers there.
